Reply: Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and parkin-linked Parkinson's disease

Reply: Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and parkin-linked Parkinson's disease

Détails bibliographiques
Auteurs principaux:	Hu, M, Brooks, D, Hajnal, J
Format:	Journal article
Publié:	2007

Documents similaires

Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and Parkin-linked Parkinson's disease.
par: Hu, M, et autres
Publié: (2006)

Molecular interactions between Parkin and FBXO7 and links with induced dopaminergic neuron degeneration in Parkinson's disease.
par: Tang, Alyssa Meiyan.
Publié: (2013)

No correlation between nigral degeneration and striatal plaques in Alzheimer's disease.
par: Love, S, et autres
Publié: (1996)

Characterization of autosomal recessive Parkinson disease-linked parkin mutations.
par: Ng, Xiao Hui.
Publié: (2009)

Disentangling the relationship between Lewy bodies and nigral neuronal loss in Parkinson's disease
par: O'Sullivan, S, et autres
Publié: (2011)

Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson’s disease
par: Rolinski, M, et autres
Publié: (2016)

Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson’s disease
par: Rolinski, M, et autres
Publié: (2016)

Exacerbation of idiopathic Parkinson's disease by naproxen.
par: Shaunak, S, et autres
Publié: (1995)

Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model.
par: Janezic, S, et autres
Publié: (2013)

Striatal origin of the pathologic beta oscillations in Parkinson's disease
par: McCarthy, M. M., et autres
Publié: (2012)

Dementia in idiopathic Parkinson's disease: prevalence and relationship with symptoms and signs of parkinsonism.
par: Ebmeier, K, et autres
Publié: (1991)

Beta burst dynamics in Parkinson’s disease OFF and ON dopaminergic medication
par: Tinkhauser, G, et autres
Publié: (2017)

Oculomotor Dysfunction in Parkinson's Disease
par: Kennard, C, et autres
Publié: (2013)

Oculomotor Dysfunction in Parkinson's Disease
par: Kennard, C, et autres
Publié: (2013)

Fuzziness, structure-dependency, and 'structural anthropology': an extended reply to Parkin
par: Shapiro, W
Publié: (1995)

Investigating the control of striatal dopamine neurotransmission by axonal calcium channels and by striatal neuromodulators: Insights for Parkinson's disease
par: Brimblecombe, K, et autres
Publié: (2014)

Parkin disease: a clinicopathologic entity?
par: Doherty, K, et autres
Publié: (2013)

CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease
par: Bengoa-Vergniory, N, et autres
Publié: (2020)

Task-related EEG-EEG coherence depends on dopaminergic activity in Parkinson's disease.
par: Cassidy, M, et autres
Publié: (2001)

Dopaminergic therapy promotes lateralized motor activity in the subthalamic area in Parkinson's disease.
par: Androulidakis, A, et autres
Publié: (2007)

Parkin regulates neuronal lipid homeostasis through SREBP2-lipoprotein lipase pathway-implications for Parkinson's disease
par: Tang, Willcyn, et autres
Publié: (2023)

Dispersed alliance, terminological change and evidence [comments on RJ Parkin in JASO 1992 (23:3) 253-62, with a reply by RJ Parkin]
par: Pfeffer, G
Publié: (1993)

The role of astrocyte dysfunction in Parkinson's disease pathogenesis
par: Booth, H, et autres
Publié: (2017)

Functional reactivation of the deafferented neostriatum by nigral transplants.
par: Björklund, A, et autres
Publié: (1981)

S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson’s Disease Models
par: Oh, Chang-Ki, et autres
Publié: (2018)

Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease.
par: Beevers, J, et autres
Publié: (2013)

Cortical structural involvement and cognitive dysfunction in early Parkinson's disease
par: Klein, J, et autres
Publié: (2018)

Programmed cell death-2 isoform1 is ubiquitinated by parkin and increased in the substantia nigra of patients with autosomal recessive Parkinson’s disease
par: Fukae, Jiro, et autres
Publié: (2015)

Unilateral loss of the swallow tail sign in a patient with idiopathic Parkinson’s disease
par: Abd Rashid, Anna Misyail, et autres
Publié: (2021)

Event related potentials, reaction time, and cognitive performance in idiopathic Parkinson's disease.
par: Ebmeier, K, et autres
Publié: (1992)

Deep brain stimulation in multiple system atrophy mimicking idiopathic Parkinson's disease.
par: Thavanesan, N, et autres
Publié: (2014)

Parkin's evidence [comments on RJ Parkin in JASO 1993 (24:1) 54-63]
par: Pfeffer, G
Publié: (1993)

Mitochondrial fragmentation in neuronal degeneration: Toward an understanding of HD striatal susceptibility
par: Cherubini, M, et autres
Publié: (2016)

6-OHDA-Lesioned Adult Zebrafish as a Useful Parkinson’s Disease Model for Dopaminergic Neuroregeneration
par: Vijayanathan, Yuganthini, et autres
Publié: (2017)

Conditional disruption of AMP kinase in dopaminergic neurons promotes Parkinson's disease-associated phenotypes in vivo
par: Hang, Liting, et autres
Publié: (2022)

Bilateral functional connectivity of the basal ganglia in patients with Parkinson's disease and its modulation by dopaminergic treatment
par: Little, S, et autres
Publié: (2013)

Beta reactivity, prospective facilitation of executive processing, and its dependence on dopaminergic therapy in Parkinson's disease.
par: Oswal, A, et autres
Publié: (2012)

Dopaminergic axons in different divisions of the adult rat striatal complex do not express vesicular glutamate transporters.
par: Moss, J, et autres
Publié: (2011)

Deep brain stimulation in the subthalamic nucleus for Parkinson’s disease can restore dynamics of striatal networks
par: Adam, Elie M, et autres
Publié: (2023)

Does idiopathic parkinsonism in Aberdeen follow intrauterine influenza?
par: Ebmeier, K, et autres
Publié: (1989)